OPTIMAL SAMPLING TIMES FOR MINIMUM VARIANCE OF CLEARANCE DETERMINATION

被引：41

作者：

DOSSING, M ^{[1
]}

VOLUND, A ^{[1
]}

POULSEN, HE ^{[1
]}

机构：

[1] NOVO RES INST,COPENHAGEN,DENMARK

来源：

关键词：

D O I：

10.1111/j.1365-2125.1983.tb01491.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：231 / 235

页数：5

共 13 条

[1] DRUG-METABOLIZING CAPACITY IN STATES OF DRUG DEPENDENCE AND WITHDRAWAL
BALLINGE.B
BROWNING, M
STEVENSO.IH
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (04) : 638 - &
[2] OPTIMUM TIME OF BLOOD-SAMPLING FOR DETERMINATION OF GLOMERULAR-FILTRATION RATE BY SINGLE-INJECTION [EDTA-CR-51] PLASMA CLEARANCE
BROCHNERMORTENSEN, J
RODBRO, P
[J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1976, 36 (08) : 795 - 800
[3] CONNEY AH, 1979, INDUCTION DRUG METAB, P585
[4] A SIMPLE METHOD FOR DETERMINATION OF ANTIPYRINE CLEARANCE
DOSSING, M
POULSEN, HE
ANDREASEN, PB
TYGSTRUP, N
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) : 392 - 396
[5] ETHANOL AND ANTIPYRINE CLEARANCE
DOSSING, M
ANDREASEN, PB
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (01) : 101 - 104
[6] ELIN RJ, 1975, CLIN PHARMACOL THER, V17, P447
[7] ENDRENNYI L, 1981, KINETIC DATA ANAL, P142
[8] GREISEN G, 1970, ACTA PHARM TOX, V38, P49
[9] Rowland M, 1980, CLIN PHARMACOKINETIC
[10] UPPAL R, 1980, INT J CLIN PHARM TH, V18, P269